Literature DB >> 7930749

Virology of measles virus.

W J Bellini1, J S Rota, P A Rota.   

Abstract

Measles virus is the prototypic member of the Morbillivirus genus of the family Paramyxoviridae. The viral genomic RNA is single-stranded, nonsegmented, and of negative polarity and encodes six major structural proteins. The two viral transmembrane glycoproteins, the hemagglutinin and fusion proteins, are both required for virus-host cell membrane fusion, while attachment to host cells is mediated by the hemagglutinin. The human CD46 molecule has been identified as a cellular receptor for measles virus. Antibodies raised against either viral glycoprotein neutralize measles virus in vitro and protect against infection. Although measles virus remains a single serotype (monotypic), nucleotide sequence analyses have identified distinct lineages among recent wild type isolates. These genetic changes were manifested by detectable antigenic variation between vaccine and wild type viruses and at some point may influence strategies for control, elimination, and eventual eradication of measles virus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930749     DOI: 10.1093/infdis/170.supplement_1.s15

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization.

Authors:  J Fayolle; B Verrier; R Buckland; T F Wild
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

2.  The use of oral fluid samples spotted on filter paper for the detection of measles virus using nested rt-PCR.

Authors:  Sogol Sheikhakbari; Talat Mokhtari-Azad; Vahid Salimi; Zahra Norouzbabaei; Simin Abbasi; Seyed Mohsen Zahraei; Shohreh Shahmahmoodi
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

3.  Human receptor for measles virus (CD46) enhances nitric oxide production and restricts virus replication in mouse macrophages by modulating production of alpha/beta interferon.

Authors:  Y Katayama; A Hirano; T C Wong
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  No evidence of measles virus in stapes samples from patients with otosclerosis.

Authors:  A B Grayeli; P Palmer; P Tran Ba Huy; J Soudant; O Sterkers; P Lebon; E Ferrary
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

5.  Isolation and complete nucleotide sequence of the measles virus IMB-1 strain in China.

Authors:  Shao-hui Ma; Li-chun Wang; Jian-sheng Liu; Hai-jing Shi; Long-ding Liu; Qi-han Li
Journal:  Virol Sin       Date:  2010-12-21       Impact factor: 4.327

6.  Human CD46 enhances nitric oxide production in mouse macrophages in response to measles virus infection in the presence of gamma interferon: dependence on the CD46 cytoplasmic domains.

Authors:  A Hirano; Z Yang; Y Katayama; J Korte-Sarfaty; T C Wong
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  Nonstructural C protein is required for efficient measles virus replication in human peripheral blood cells.

Authors:  C Escoffier; S Manié; S Vincent; C P Muller; M Billeter; D Gerlier
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

8.  Human cell receptor CD46 is down regulated through recognition of a membrane-proximal region of the cytoplasmic domain in persistent measles virus infection.

Authors:  A Hirano; S Yant; K Iwata; J Korte-Sarfaty; T Seya; S Nagasawa; T C Wong
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

9.  Remission of disseminated cancer after systemic oncolytic virotherapy.

Authors:  Stephen J Russell; Mark J Federspiel; Kah-Whye Peng; Caili Tong; David Dingli; William G Morice; Val Lowe; Michael K O'Connor; Robert A Kyle; Nelson Leung; Francis K Buadi; S Vincent Rajkumar; Morie A Gertz; Martha Q Lacy; Angela Dispenzieri
Journal:  Mayo Clin Proc       Date:  2014-05-14       Impact factor: 7.616

10.  Functional and structural interactions between measles virus hemagglutinin and CD46.

Authors:  O Nussbaum; C C Broder; B Moss; L B Stern; S Rozenblatt; E A Berger
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.